Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4745292 | 0.86 | ALDH1A1 (0.32) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| SCHEMBL9667176 | 0.82 | — | — | |
| SCHEMBL8776143 | 0.82 | — | — | |
| SCHEMBL49756 | 0.82 | — | — | |
| SCHEMBL172655 | 0.82 | — | — | |
| SCHEMBL9667218 | 0.82 | — | — | |
| Bromide SCHEMBL11537123 | 0.78 | TSHR (0.41) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| SCHEMBL17041922 | 0.78 | TSHR (0.41) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| SCHEMBL28225830 | 0.78 | TSHR (0.41) | ALDH1A1TP53HSP90AA1CYP3A4THRB | |
| Hydrochloric Acid SCHEMBL6813796 | 0.78 | TSHR (0.41) | ALDH1A1TP53HSP90AA1CYP3A4THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2552990-B1 | POLYURETHANE/POLYUREA SPRAY ELASTOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-04-19 | — | — | EP | claimed |
| EP-2552990-A1 | POLYURETHANE/POLYUREA SPRAY ELASTOMERS | Dow Global Technologies LLC (US) | 2013-02-06 | — | — | EP | claimed |
| US-20130018147-A1 | POLYURETHANE/POLYUREA SPRAY ELASTOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-01-17 | — | — | US | claimed |
| WO-2011123241-A1 | POLYURETHANE/POLYUREA SPRAY ELASTOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-10-06 | — | — | WO | claimed |
| US-20240376246-A1 | ONE-POT PROCESS FOR THE PRODUCTION OF POLYCARBODIIMIDE CURED POLYMERS | BASF SE (DE) | 2024-11-14 | — | — | US | disclosed |
| EP-4402191-A1 | ONE-POT PROCESS FOR THE PRODUCTION OF POLYCARBODIIMIDE CURED POLYMERS | BASF SE (DE) | 2024-07-24 | — | — | EP | disclosed |
| WO-2023041443-A1 | ONE-POT PROCESS FOR THE PRODUCTION OF POLYCARBODIIMIDE CURED POLYMERS | BASF SE (DE) | 2023-03-23 | — | — | WO | disclosed |
| US-20180037540-A1 | DIAZADIENYL COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, METHOD FOR PRODUCING THIN FILM, AND DIAZADIENE COMPOUND | ADEKA CORPORATION (JP) | 2018-02-08 | — | — | US | disclosed |
| EP-2552990-B1 | POLYURETHANE/POLYUREA SPRAY ELASTOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-04-19 | — | — | EP | disclosed |
| US-20140373918-A1 | PHOTOVOL TAlC MODULES AND METHODS OF MAKING THE SAME | PPG INDUSTRIES OHIO, INC. | 2014-12-25 | — | — | US | disclosed |
| EP-2552990-A1 | POLYURETHANE/POLYUREA SPRAY ELASTOMERS | Dow Global Technologies LLC (US) | 2013-02-06 | — | — | EP | disclosed |
| WO-2013009372-A1 | PHOSPHORUS-CONTAINING SECONDARY AMINE COMPOUNDS | HUNTSMAN PETROCHEMICAL LLC (US) | 2013-01-17 | — | — | WO | disclosed |
| US-20080033210-A1 | DIIMINES AND SECONDARY DIAMINES | ALBEMARLE CORPORATION (US) | 2008-02-07 | — | — | US | disclosed |
| US-20080004406-A1 | DIIMINES AND SECONDARY DIAMINES | ALBEMARLE CORPORATION (US) | 2008-01-03 | — | — | US | disclosed |
| EP-1868987-A1 | DIIMINES AND SECONDARY DIAMINES | ALBEMARLE CORPORATION (US) | 2007-12-26 | — | — | EP | disclosed |
| US-20070270566-A1 | Chain Extenders | ALBEMARLE CORPORATION (US) | 2007-11-22 | — | — | US | disclosed |
| US-7288677-B2 | Diimines and secondary diamines | ALBEMARLE CORPORATION (US) | 2007-10-30 | — | — | US | disclosed |
| US-20070073030-A1 | Chain Extenders | ALBEMARLE CORPORATION (US) | 2007-03-29 | — | — | US | disclosed |
| WO-2006104528-A1 | DIIMINES AND SECONDARY DIAMINES | ALBEMARLE CORPORATION (US) | 2006-10-05 | — | — | WO | disclosed |
| US-20060217567-A1 | Diimines and secondary diamines | ALBEMARLE CORPORATION | 2006-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004406-A1 | DIIMINES AND SECONDARY DIAMINES | DDT, DDC, AOC1 | ALDH1A1 412/4885TP53 3269/4885HSP90AA1 4456/4885 |
| US-20070270566-A1 | Chain Extenders | DDC, PARG, ODC1 | ALDH1A1 146/4885TP53 3740/4885HSP90AA1 3419/4885 |
| US-20080033210-A1 | DIIMINES AND SECONDARY DIAMINES | DDT, DDC, AOC1 | ALDH1A1 412/4885TP53 3269/4885HSP90AA1 4456/4885 |
| US-20180037540-A1 | DIAZADIENYL COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, METHOD FOR PRODUCING THIN FILM, AND DIAZADIENE COMPOUND | DRD4, DRD2, DRD1 | ALDH1A1 4120/4885TP53 3779/4885HSP90AA1 4758/4885 |
| US-20060217567-A1 | Diimines and secondary diamines | DDT, DDC, AOC1 | ALDH1A1 412/4885TP53 3269/4885HSP90AA1 4456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.